Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of L-CARNITINE patients who developed HALLUCINATION, AUDITORY.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking L-CARNITINE reported HALLUCINATION, AUDITORY to the FDA. A total of 333 L-CARNITINE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between L-CARNITINE and HALLUCINATION, AUDITORY. In doing so, we compare L-CARNITINE with other drugs that cause HALLUCINATION, AUDITORY, to help you evaluate whether or not L-CARNITINE causes HALLUCINATION, AUDITORY. Likewise, this page shows the most highly-reported side effects of L-CARNITINE, so you can see if HALLUCINATION, AUDITORY ranks among L-CARNITINE's most well-known side effects.
Summary Statistics
Reports of L-CARNITINE causing HALLUCINATION, AUDITORY: 1
Reports of any side effect of L-CARNITINE : 333
Percentage of L-CARNITINE patients where HALLUCINATION, AUDITORY is a reported side effect: 0.3003%

FDA reports of any drug causing HALLUCINATION, AUDITORY : 5771
Average percentage for all medicated patients where HALLUCINATION, AUDITORY is reported as a complication: 0.0362%

Physician opinion on L-CARNITINE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing L-CARNITINE:
DRUG USE FOR UNKNOWN INDICATION ( 24 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 24 patients )
VITAMIN SUPPLEMENTATION ( 6 patients )
SUPPLEMENTATION THERAPY ( 4 patients )
HEPATITIS ( 4 patients )
ILL-DEFINED DISORDER ( 3 patients )
WEIGHT CONTROL ( 3 patients )
MINERAL SUPPLEMENTATION ( 2 patients )
MUSCULAR DYSTROPHY ( 2 patients )
NUTRITIONAL SUPPORT ( 2 patients )
ASPARTATE AMINOTRANSFERASE INCREASED ( 1 patients )
MALABSORPTION ( 1 patients )
ATRIAL FIBRILLATION ( 1 patients )
MEDIUM-CHAIN ACETYL-COENZYME A DEHYDROGENASE DEFICIENCY ( 1 patients )
CARDIAC DISORDER ( 1 patients )
MITRAL VALVE PROLAPSE ( 1 patients )
CARNITINE DEFICIENCY ( 1 patients )
MUSCLE FATIGUE ( 1 patients )
CONVULSION ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
PARAESTHESIA ( 1 patients )
FATIGUE ( 1 patients )
HYPERAMMONAEMIC ENCEPHALOPATHY ( 1 patients )
ACIDOSIS ( 1 patients )
INCREASED APPETITE ( 1 patients )
ASTHENIA ( 1 patients )
MEDICAL DIET ( 1 patients )
BLOOD LACTATE DEHYDROGENASE ABNORMAL ( 1 patients )
CARNITINE DECREASED ( 1 patients )
MUSCLE ATROPHY ( 1 patients )
CHRONIC FATIGUE SYNDROME ( 1 patients )
CROHN'S DISEASE ( 1 patients )
EPILEPSY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HALLUCINATION, AUDITORY:

SEROQUEL (1487 patients)
RISPERDAL (557 patients)
ZYPREXA (444 patients)
CHANTIX (416 patients)
CLOZARIL (377 patients)
RISPERIDONE (346 patients)
PAXIL (338 patients)
ABILIFY (288 patients)
ZOLOFT (262 patients)
HALDOL (257 patients)
LORAZEPAM (218 patients)
CLOZAPINE (212 patients)
GEODON (203 patients)
LEXAPRO (186 patients)
CYMBALTA (183 patients)
KLONOPIN (180 patients)
PROZAC (177 patients)
ASPIRIN (174 patients)
DEPAKOTE (173 patients)
EFFEXOR (173 patients)
ATIVAN (172 patients)
SEROQUEL XR (171 patients)
XANAX (169 patients)
DIAZEPAM (165 patients)
CLONAZEPAM (161 patients)
OLANZAPINE (161 patients)
TOPROL-XL (159 patients)
MIRTAZAPINE (157 patients)
LAMICTAL (147 patients)
NEURONTIN (146 patients)
AMBIEN (145 patients)
WELLBUTRIN (143 patients)
COGENTIN (140 patients)
RISPERDAL CONSTA (139 patients)
CELEXA (138 patients)
ARIPIPRAZOLE (136 patients)
SIMVASTATIN (135 patients)
HALOPERIDOL (132 patients)
CITALOPRAM HYDROBROMIDE (130 patients)
TRAZODONE HCL (129 patients)
TEGRETOL (127 patients)
CONCERTA (127 patients)
LIPITOR (127 patients)
LITHIUM CARBONATE (127 patients)
NEXIUM (123 patients)
SUBOXONE (121 patients)
STRATTERA (119 patients)
PRILOSEC (110 patients)
FLUOXETINE (108 patients)
PAROXETINE HCL (108 patients)
METFORMIN HCL (106 patients)
LYRICA (103 patients)
LISINOPRIL (101 patients)
RITALIN (101 patients)
ALBUTEROL (99 patients)
VALPROATE SODIUM (99 patients)
TOPIRAMATE (98 patients)
ZOCOR (98 patients)
INVEGA SUSTENNA (97 patients)
ATENOLOL (96 patients)
OMEPRAZOLE (95 patients)
TRAMADOL HCL (95 patients)
IBUPROFEN (90 patients)
HYDROCHLOROTHIAZIDE (90 patients)
SINGULAIR (89 patients)
QUETIAPINE (89 patients)
SYNTHROID (89 patients)
VISTARIL (86 patients)
EFFEXOR XR (86 patients)
TOPAMAX (85 patients)
LASIX (84 patients)
POTASSIUM CHLORIDE (83 patients)
OXYCONTIN (83 patients)
INVEGA (83 patients)
PREVACID (83 patients)
SERTRALINE HYDROCHLORIDE (81 patients)
ALL OTHER THERAPEUTIC PRODUCTS (81 patients)
KEPPRA (78 patients)
VFEND (77 patients)
TAMIFLU (77 patients)
BETASERON (76 patients)
ALPRAZOLAM (75 patients)
VIOXX (74 patients)
LEVOTHYROXINE SODIUM (73 patients)
RELENZA (71 patients)
VALIUM (70 patients)
PREDNISONE (70 patients)
HYDROXYZINE (67 patients)
MOTRIN (67 patients)
FOSAMAX (67 patients)
CLONIDINE (67 patients)
BENADRYL (66 patients)
GABAPENTIN (66 patients)
NITROGLYCERIN (65 patients)
NICOTINE (65 patients)
ACETAMINOPHEN (64 patients)
VICODIN (64 patients)
PEG-INTRON (62 patients)
CARBAMAZEPINE (61 patients)
QUETIAPINE FUMARATE (61 patients)
AMISULPRIDE (61 patients)
PERCOCET (60 patients)
TEMAZEPAM (59 patients)
REMERON (59 patients)
LAMOTRIGINE (59 patients)
NORVASC (58 patients)
MORPHINE (58 patients)
FOLIC ACID (58 patients)
OXYCODONE HCL (57 patients)
ACTONEL (56 patients)
DARVOCET (56 patients)
LITHIUM (55 patients)
AMLODIPINE (54 patients)
LANSOPRAZOLE (53 patients)
COFFEE (53 patients)
DURAGESIC-100 (53 patients)
CELEBREX (53 patients)
AVONEX (52 patients)
ZANAFLEX (51 patients)
BECLAMIDE (50 patients)
ULTRAM (50 patients)
CITALOPRAM (50 patients)
COUMADIN (50 patients)
METFORMIN (49 patients)
CORTISONE (49 patients)
ZONISAMIDE (49 patients)
MYCOPHENOLATE MOFETIL (CELLCEPT) (49 patients)
VALPROIC ACID (48 patients)
PRISTIQ (48 patients)
ZANTAC (48 patients)
WELLBUTRIN SR (47 patients)
RIBAVIRIN (47 patients)
PLAVIX (47 patients)
PRIALT (46 patients)
TRILEPTAL (46 patients)
ZOPICLONE (45 patients)
PREDNISOLONE (45 patients)
AKINETON (45 patients)
VENLAFAXINE HCL (45 patients)
ELAVIL (44 patients)
FUROSEMIDE (44 patients)
NAMENDA (44 patients)
MULTI-VITAMIN (43 patients)
BACLOFEN (43 patients)
FLEXERIL (43 patients)
PROTONIX (43 patients)
REMICADE (41 patients)
INSULIN (41 patients)
LUNESTA (41 patients)
FLUCONAZOLE (41 patients)
CIPROFLOXACIN (41 patients)
TRAZODONE (40 patients)
ACCUTANE (40 patients)
RAMIPRIL (40 patients)
ICL670A ICL+DISTAB (40 patients)
OXYCODONE (40 patients)
NORETHINDRONE (39 patients)
RANITIDINE (39 patients)
METHOTREXATE (39 patients)
SERTRALINE HCL (39 patients)
PROPRANOLOL (39 patients)
ARICEPT (38 patients)
ZOLPIDEM (38 patients)
HYDROCODONE (37 patients)
MIRAPEX (37 patients)
ALLOPURINOL (37 patients)
ENBREL (37 patients)
PEGASYS (37 patients)
PROMETHAZINE (36 patients)
TRAMADOL HYDROCHLORIDE (36 patients)
MAGNESIUM OXIDE (36 patients)
REBIF (36 patients)
CELLCEPT (35 patients)
NAVANE (35 patients)
ARTANE (35 patients)
ESCITALOPRAM (35 patients)
VYVANSE (35 patients)
GLYBURIDE (35 patients)
BUSPAR (35 patients)
BENZTROPINE MESYLATE (34 patients)
VALTREX (34 patients)
BACTRIM (34 patients)
PALIPERIDONE (34 patients)
TYLENOL (CAPLET) (34 patients)
WELLBUTRIN XL (34 patients)
LEPONEX (33 patients)
AMOXICILLIN (33 patients)
METOPROLOL (33 patients)
CHAMPIX (33 patients)
BUPROPION HCL (32 patients)
REQUIP (32 patients)
PAROXETINE HYDROCHLORIDE (32 patients)
HALCION (32 patients)
AVANDIA (32 patients)
DEPAS (32 patients)
SULPIRIDE (31 patients)
COLACE (31 patients)
SKELAXIN (31 patients)
CEPHALEXIN (31 patients)
AMITRIPTYLINE HCL (30 patients)
SERZONE (30 patients)
FERROUS SULFATE TAB (30 patients)
PROVIGIL (30 patients)
VITAMIN B-12 (30 patients)
METRONIDAZOLE (30 patients)
GLUCOPHAGE (30 patients)
NEORAL (30 patients)
METOPROLOL TARTRATE (30 patients)
METHADONE HCL (30 patients)
NAPROXEN (30 patients)
Most common side effects for patients taking L-CARNITINE:
DEHYDRATION (21 patients)
ARTHRALGIA (17 patients)
NAUSEA (17 patients)
FATIGUE (17 patients)
CONVULSION (16 patients)
ABDOMINAL PAIN (15 patients)
DYSPNOEA (15 patients)
DIZZINESS (15 patients)
DRUG INEFFECTIVE (15 patients)
ANAEMIA (14 patients)
ELECTROCARDIOGRAM QT PROLONGED (14 patients)
LETHARGY (13 patients)
EXTRASYSTOLES (13 patients)
GASTROENTERITIS (13 patients)
CONFUSIONAL STATE (13 patients)
PAIN (12 patients)
BACK PAIN (12 patients)
GAIT DISTURBANCE (12 patients)
MYOCARDIAL INFARCTION (12 patients)
HAEMOGLOBIN DECREASED (11 patients)
WEIGHT DECREASED (11 patients)
INJURY (11 patients)
CEREBRAL ISCHAEMIA (11 patients)
OEDEMA PERIPHERAL (11 patients)
HEADACHE (11 patients)
DEATH (11 patients)
INSOMNIA (11 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (11 patients)
SOMNOLENCE (10 patients)
ASTHENIA (10 patients)
HYPOTENSION (10 patients)
URINARY TRACT INFECTION (10 patients)
VOMITING (10 patients)
SPINAL COMPRESSION FRACTURE (9 patients)
ANGINA PECTORIS (9 patients)
MYOCARDIAL ISCHAEMIA (9 patients)
PAIN IN EXTREMITY (9 patients)
CHRONIC MYELOID LEUKAEMIA (9 patients)
WEIGHT INCREASED (8 patients)
HYPERTENSION (8 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (8 patients)
TROPONIN I INCREASED (8 patients)
CEREBRAL HAEMORRHAGE (8 patients)
PNEUMONIA (8 patients)
DECREASED APPETITE (8 patients)
DIARRHOEA (8 patients)
DUODENAL ULCER (8 patients)
ALANINE AMINOTRANSFERASE INCREASED (7 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (7 patients)
LEUKOPENIA (7 patients)
TRANSAMINASES INCREASED (7 patients)
INTESTINAL OBSTRUCTION (7 patients)
CHEST PAIN (7 patients)
CONSTIPATION (7 patients)
RENAL FAILURE (7 patients)
INFLAMMATION (7 patients)
AGITATION (6 patients)
AMMONIA INCREASED (6 patients)
PERIPHERAL ISCHAEMIA (6 patients)
ASPIRATION (6 patients)
ATRIAL FIBRILLATION (6 patients)
LYMPHOCYTOSIS (6 patients)
MUSCULAR WEAKNESS (6 patients)
MYALGIA (6 patients)
RENAL FAILURE ACUTE (6 patients)
HYPOXIA (6 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (6 patients)
BURNING SENSATION (6 patients)
CARDIAC FAILURE (6 patients)
OSTEONECROSIS (6 patients)
PYREXIA (6 patients)
RETICULOCYTE COUNT DECREASED (6 patients)
DEEP VEIN THROMBOSIS (6 patients)
THROMBOCYTOPENIA (6 patients)
DRUG INTERACTION (6 patients)
TROPONIN INCREASED (6 patients)
ABDOMINAL DISCOMFORT (5 patients)
ABDOMINAL DISTENSION (5 patients)
MALAISE (5 patients)
THERAPEUTIC RESPONSE DECREASED (5 patients)
GASTRITIS (5 patients)
PLATELET COUNT DECREASED (5 patients)
VISION BLURRED (5 patients)
BUNDLE BRANCH BLOCK RIGHT (5 patients)
MENTAL DISORDER (5 patients)
MENTAL IMPAIRMENT (5 patients)
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
GASTRIC ULCER (5 patients)
HEPATOTOXICITY (5 patients)
INCORRECT DOSE ADMINISTERED (5 patients)
DYSGEUSIA (4 patients)
SPEECH DISORDER (4 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (4 patients)
VENTRICULAR EXTRASYSTOLES (4 patients)
AFFECT LABILITY (4 patients)
HAEMATOCRIT DECREASED (4 patients)
RESPIRATORY FAILURE (4 patients)
HYPERPARATHYROIDISM SECONDARY (4 patients)
LOSS OF CONSCIOUSNESS (4 patients)
MULTIPLE EPIPHYSEAL DYSPLASIA (4 patients)
ANXIETY (4 patients)
OFF LABEL USE (4 patients)
HEART RATE INCREASED (4 patients)
ASTHMA (4 patients)
ATELECTASIS (4 patients)
EPILEPSY (4 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (4 patients)
BLOOD CREATININE INCREASED (4 patients)
RASH GENERALISED (4 patients)
RESPIRATORY DISORDER (4 patients)
RESPIRATORY DISTRESS (4 patients)
BONE MARROW FAILURE (4 patients)
SUPRAVENTRICULAR EXTRASYSTOLES (4 patients)
BREAST CANCER METASTATIC (4 patients)
VERTIGO (4 patients)
VIRAL INFECTION (4 patients)
LABORATORY TEST ABNORMAL (4 patients)
LIVER FUNCTION TEST ABNORMAL (4 patients)
CARDIOGENIC SHOCK (4 patients)
FALL (4 patients)
FEELING ABNORMAL (4 patients)
FLUSHING (4 patients)
NEPHROLITHIASIS (4 patients)
NEUROPATHY PERIPHERAL (4 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (4 patients)
GRANULOMA (4 patients)
COLON CANCER (4 patients)
PARAESTHESIA (4 patients)
PNEUMONIA BACTERIAL (4 patients)
CONDITION AGGRAVATED (4 patients)
HYPERBILIRUBINAEMIA (4 patients)
COUGH (4 patients)
DELUSION (4 patients)
INFECTION (4 patients)
SINUS BRADYCARDIA (4 patients)
TREMOR (4 patients)
DISEASE PROGRESSION (4 patients)
INTERSTITIAL LUNG DISEASE (4 patients)
UNEVALUABLE EVENT (4 patients)
ABDOMINAL PAIN UPPER (3 patients)
ABNORMAL BEHAVIOUR (3 patients)
DYSPHONIA (3 patients)
PROPHYLAXIS OF NAUSEA AND VOMITING (3 patients)
ECONOMIC PROBLEM (3 patients)
NON-NEUTRALISING ANTIBODIES POSITIVE (3 patients)
MULTI-ORGAN FAILURE (3 patients)
ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE (3 patients)
FEMUR FRACTURE (3 patients)
PLEURAL EFFUSION (3 patients)
PELVIC PAIN (3 patients)
RESTLESSNESS (3 patients)
SCIATICA (3 patients)
SYNCOPE (3 patients)
MELAENA (3 patients)
ESCHERICHIA INFECTION (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CHOLESTEROL INCREASED (3 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (3 patients)
GASTROINTESTINAL MOTILITY DISORDER (3 patients)
BLOOD GLUCOSE INCREASED (3 patients)
BLOOD HOMOCYSTEINE INCREASED (3 patients)
RASH (3 patients)
PSYCHOMOTOR HYPERACTIVITY (3 patients)
BLOOD UREA INCREASED (3 patients)
IMPETIGO (3 patients)
INCOHERENT (3 patients)
TACHYPNOEA (3 patients)
TUMOUR NECROSIS (3 patients)
LEUKOCYTOSIS (3 patients)
CARDIAC ARREST (3 patients)
CARDIAC DISORDER (3 patients)
MELAS SYNDROME (3 patients)
METABOLIC ACIDOSIS (3 patients)
ELECTROENCEPHALOGRAM ABNORMAL (3 patients)
EMOTIONAL DISTRESS (3 patients)
ENCEPHALOMALACIA (3 patients)
EPISTAXIS (3 patients)
ERYTHEMA (3 patients)
CEREBRAL INFARCTION (3 patients)
NASOPHARYNGITIS (3 patients)
HAEMATEMESIS (3 patients)
OSTEOPOROSIS (3 patients)
COMMUNICATION DISORDER (3 patients)
PLEURAL FIBROSIS (3 patients)
PULMONARY CONGESTION (3 patients)
CONGESTIVE CARDIOMYOPATHY (3 patients)
HALLUCINATION, VISUAL (3 patients)
HYPERAMMONAEMIA (3 patients)
RECTAL HAEMORRHAGE (3 patients)
CRYPTOGENIC ORGANIZING PNEUMONIA (3 patients)
RENAL DISORDER (3 patients)
HYPOAESTHESIA (3 patients)
DELIRIUM (3 patients)
RETCHING (3 patients)
TACHYCARDIA (3 patients)
TRANSPLANT REJECTION (3 patients)
SKIN DISCOLOURATION (3 patients)
IRRITABLE BOWEL SYNDROME (3 patients)
DRY SKIN (3 patients)
JOINT STIFFNESS (3 patients)
DYSARTHRIA (3 patients)
ANORECTAL DISCOMFORT (2 patients)
LUNG INFECTION (2 patients)
MEDICAL DEVICE DISCOMFORT (2 patients)
MELANOSIS COLI (2 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (2 patients)
CARDIAC FAILURE ACUTE (2 patients)
MEDICATION ERROR (2 patients)
CARDIAC MURMUR (2 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for L-CARNITINE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about HALLUCINATION, AUDITORY and L-CARNITINE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking L-CARNITINE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in L-CARNITINE. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for L-CARNITINE experts. If you are a healthcare provider experienced in prescribing L-CARNITINE, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use